Trial intelligence / Profile preview

Continuous intertransverse interproximal block timing for analgesia after pleurectomy/decortication

jRCT1051240111Recruiting

Start
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of levobupivacaine in pleural mesothelioma and postoperative pain (2 arms). Primary endpoint: Postoperative quality of life. Started Apr 2024; status: recruiting.

02

Drugs

levobupivacaine
03

Conditions

pleural mesotheliomapostoperative pain

Beyond the preview

Go deeper on jRCT1051240111.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1051240111.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call